A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines-Reference-Cited by-同舟云学术

A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines

Published:2015-11 Issue:11 Volume:41 Page:1310-1319
ISSN:1076-0512
Container-title:Dermatologic Surgery
language:en
Short-container-title:

Author:

Kane Michael A. C.,Gold Michael H.,Coleman William P.,Jones Derek H.,Tanghetti Emil A.,Alster Tina S.,Rohrer Tom E.,Burgess Cheryl M.,Shamban Ava T.,Finn Eleanor

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Dermatology,General Medicine,Surgery

Reference12 articles.

1. Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products;Frevert;Drugs R D,2015

2. Botulinum A exotoxin use in clinical dermatology;Carruthers;J Am Acad Dermatol,1996

3. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin;Carruthers;Dermatol Surg,1998

4. Rapid onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar lines;Beer;J Drugs Dermatol,2011

5. A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia;Benecke;Neurology,2005

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cosmetic concerns and special considerations for specific populations: Populations of African ancestry;Cosmetic Procedures in Skin of Color;2025

2. Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women;Dermatology and Therapy;2024-07-02

3. Efficacy and Safety of LetibotulinumtoxinA in the Treatment of Moderate and Severe Glabellar Lines in Females 35 to 50 Years of Age: Post Hoc Analyses of the Phase 3 Clinical Study Data;Aesthetic Surgery Journal Open Forum;2024

4. Tailored Indications for Different Neurotoxins;Plastic and Reconstructive Surgery - Global Open;2023-11

5. IncobotulinumtoxinA for Glabellar Frown Lines in Chinese Subjects: A Randomized, Double-blind, Active-Controlled Phase-3 Study;Plastic and Reconstructive Surgery - Global Open;2023-05